UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network

The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19.  The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including in the cities of Birmingham, London, Edinburgh, Glasgow, Sheffield, Liverpool, Cardiff and Cambridge.  Nanopore sequencing can deliver a whole genome sequence of the virus in as little as 7 hours, on the portable MinION